Acetazolamide and autosomal dominant nocturnal frontal lobe epilepsy [1]

Epilepsia

Volumn 44, Issue 7, 2003, Pages 986-987

  Varadkar, Sophia ^a,b   Duncan, John S ^c,d   Cross, J Helen ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d EPILEPSY SOCIETY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; DIAZEPAM; GABAPENTIN; ION CHANNEL; LORAZEPAM; NICOTINIC RECEPTOR; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID;

AUTOSOMAL DOMINANT INHERITANCE; DRUG EFFECT; DRUG MECHANISM; ELECTROENCEPHALOGRAM; FRONTAL LOBE EPILEPSY; GENE MUTATION; HUMAN; LETTER; NOCTURNAL SEIZURE; PRIORITY JOURNAL;

ACETAZOLAMIDE; ADOLESCENT; ANTICONVULSANTS; CHILD; CHROMOSOME ABERRATIONS; EPILEPSY, FRONTAL LOBE; FEMALE; FOLLOW-UP STUDIES; GENES, DOMINANT; HUMANS; PHENOTYPE; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 0037477783     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2003.53002.x     Document Type: Letter

References (11)

1. Scheffer IE, Bhatia KP, Lopes-Cendes, et al. Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder. Lancet 1994;343:515-7.
2. Scheffer IE, Bhatia KP, Lopes-Cendes, et al. Autosomal dominant nocturnal frontal lobe epilepsy: a distinctive clinical disorder. Brain 1995;118:61-73.
3. Provini F, Plazzi G, Tinuper P, et al. Nocturnal frontal lobe epilepsy: a clinical and polygraphic overview of 100 consecutive cases. Brain 1999;122:1017-31.
4. Steinlein OK, Mulley JC, Propping P, et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant frontal lobe epilepsy. Nat Genet 1995;11:201-3.
5. Steinlein OK, Magnusson A, Stoodt J, et al. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet 1997;6:943-7.
6. Philips HA, Favre I, Kirkpatrick M, et al. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet 2001;68:225-31.
7. Bergstrom WH, Garzoli RF, Lombroso C, et al. Observations on metabolic and clinical effects of carbonic anhydrase inhibitors in epileptics. Am J Dis Child 1952;84:71-3.
8. Lombroso CT, Davidson DT Jr, Gross-Bianchi ML. Further evaluation of acetazolamide (Diamox) in treatment of epilepsy. JAMA 1956;160:268-72.
9. Oles KS, Penry JK, Cole DLW, et al. Use of acetazolamide as an adjunct to carbamazepine in refractory partial seizures. Epilepsia 1989;30:74-8.
10. Forsythe WI, Owens JR, Toothill C. Effectiveness of acetazolamide in the treatment of carbamazepine-resistant epilepsy in children. Dev Med Child Neurol 1981;23:761-9.
11. 2+channel: a novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis. Ann Neurol 2000;48:304-12.